Acadia Pharmaceuticals | Ventas



Sales Cambio Fecha
Acadia Pharmaceuticals USD 259.6M 9.2M 2024-12
ALKERMES USD 430M 51.9M 2024-12
Alnylam Pharmaceuticals USD 593.17M 92.25M 2024-12
Biogen USD 2.45B 11.1M 2024-12
BioMarin Pharmaceutical USD 747.31M 1.57M 2024-12
Bristol-Myers Squibb USD 12.34B 450M 2024-12
Corcept Therapeutics USD 181.89M 656K 2024-12
Cytokinetics USD 16.93M 16.46M 2024-12
Eisai JPY 216.14B 20.15B 2024-12
Eli Lilly USD 13.53B 2.09B 2024-12
Incyte USD 1.18B 40.83M 2024-12
J&J USD 21.89B 630M 2025-03
Moderna USD 966M 896M 2024-12
Neurocrine Biosciences USD 627.7M 5.6M 2024-12
Pfizer USD 17.76B 61M 2024-12
Prothena USD 2.12M 1.15M 2024-12
PTC Therapeutics USD 213.17M 16.39M 2024-12
Sarepta Therapeutics USD 658.41M 191.24M 2024-12
Ultragenyx Pharmaceutical USD 164.88M 25.38M 2024-12
Vertex Pharmaceuticals USD 2.91B 140.1M 2024-12



Acadia Pharmaceuticals Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2025.